ELRIG Drug Discovery 2023

Nuclera is attending Antibody Engineering & Therapeutics Europe 2026 in Basel. Find out more about eProtein Discovery™ Cell Free Protein Expression.

In this exclusive launch webinar, Sumit Kalsi, Associate Director of Product Research at Nuclera, will unveil a breakthrough solution: Nuclera's Rapid Antibody Screening Service. He will demonstrate how integrating a 96-plex cell-free binary expression and yes/no binding screen can act as the ultimate early filter for your pipeline.